|
1
|
Institute of Medicine (US): Dietary
Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron,
Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel,
Silicon, Vanadium, and Zinc. National Academies Press, Washington,
DC, 2001.
|
|
2
|
NIH Office of Dietary Supplements.
Molybdenum Fact Sheet for Health Professionals. Updated 2023.
https://ods.od.nih.gov/factsheets/Molybdenum-HealthProfessional/.
Accessed......
|
|
3
|
Hille R, Nishino T and Bittner F:
Molybdenum enzymes in higher organisms. Coord Chem Rev.
255:1179–1205. 2011.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Schwarz G and Mendel RR: Molybdenum
cofactor biosynthesis and molybdenum enzymes. Annu Rev Plant Biol.
57:623–647. 2006.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Zoli A, Altomonte L, Caricchio R, Galossi
A, Mirone L, Ruffini MP and Magaró M: Serum zinc and copper in
active rheumatoid arthritis: correlation with interleukin 1 beta
and tumour necrosis factor alpha. Clin Rheumatol. 17:378–382.
1998.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Tarp U, Overvad K, Hansen JC and Thorling
EB: Low selenium level in severe rheumatoid arthritis. Scand J
Rheumatol. 14:97–101. 1985.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Stone J, Doube A, Dudson D and Wallace J:
Inadequate calcium, folic acid, vitamin E, zinc, and selenium
intake in rheumatoid arthritis patients: results of a dietary
survey. Semin Arthritis Rheum. 27:180–185. 1997.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Pacher P, Nivorozhkin A and Szabó C:
Therapeutic effects of xanthine oxidase inhibitors: Renaissance
half a century after the discovery of allopurinol. Pharmacol Rev.
58:87–114. 2006.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Brewer GJ: Tetrathiomolybdate anticopper
therapy for Wilson's disease inhibits angiogenesis, fibrosis and
inflammation. J Cell Mol Med. 7:11–20. 2003.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Brewer GJ: Copper control as an
antiangiogenic anticancer therapy: Lessons from treating Wilson's
disease. Exp Biol Med (Maywood). 226:665–673. 2001.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Moss M: Effects of molybdenum on pain and
general health: A pilot study. J Nutr Environ Med. 5:55–61.
1995.
|
|
12
|
Laniak OT, Winans T, Patel A, Park J and
Perl A: Redox pathogenesis in rheumatic diseases. ACR Open
Rheumatol. 6:334–346. 2024.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Zamudio-Cuevas Y, Martínez-Flores K,
Martínez-Nava GA, Clavijo-Cornejo D, Fernández-Torres J and
Sánchez-Sánchez R: Rheumatoid Arthritis and Oxidative Stress. Cell
Mol Biol (Noisy-le-grand). 68:174–184. 2022.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Islam MT, Sarkar C, Hossain R, Bhuia MS,
Mardare I, Kulbayeva M, Ydyrys A, Calina D, Habtemariam S,
Kieliszek M, et al: Therapeutic strategies for rheumatic diseases
and disorders: Targeting redox imbalance and oxidative stress.
Biomed Pharmacother. 164(114900)2023.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Liu X, Wang J, Lou T, Tang Q, Fang Z,
Zhang W and Hu Y: Immunometabolism in rheumatoid arthritis:
mechanisms, biomarkers, and the path to precision medicine. Front
Immunol. 17(1691946)2026.PubMed/NCBI View Article : Google Scholar
|
